Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mutant DMPK 3'UTR CUG-repeat RNA foci are pathogenic nuclear aggregates formed by the transcription of the DMPK gene containing expanded CTG repeats (Thornton, 2014; PubMed: 25037086). In Myotonic Dystrophy Type 1 (DM1), these expanded CUG repeats in the mRNA's 3' untranslated region (UTR) fold into stable hairpin structures that accumulate in the nucleus (Miller et al., 2000; PubMed: 10944116). These foci act as a molecular sink, sequestering essential RNA-binding proteins, most notably the Muscleblind-like (MBNL) family, while causing the upregulation of CELF1 (Nature Reviews Disease Primers, 2021; DOI: 10.1038/s41572-020-00232-7). This protein imbalance leads to widespread spliceopathies, where fetal isoforms of various proteins are incorrectly expressed in adult tissues, resulting in the multi-systemic symptoms of DM1, such as myotonia, muscle wasting, and cardiac conduction defects (JCI, 2018; DOI: 10.1172/JCI123854). Therapeutic strategies targeting these foci include antibody-oligonucleotide conjugates (AOCs) like delpacibart zotadirsen and antisense oligonucleotides (ASOs) designed to either degrade the mutant RNA or displace sequestered proteins to restore normal cellular function (Avidity Biosciences, 2024; Dyne Therapeutics, 2024).
RNase H-mediated RNA degradation, RNA interference (RNAi), and steric hindrance to prevent protein sequestration (Nature Reviews Disease Primers, 2021; DOI: 10.1038/s41572-020-00232-7).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myotonic dystrophy protein kinase 3' untranslated region CUG-repeat RNA foci (DMPK CUG-repeat RNA foci) (DMPK CUG-repeat RNA foci).